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Defects in mid-facial development, including cleft lip/palate, account for a large number
of human birth defects annually. In many cases, aberrant gene expression results in
either a reduction in the number of neural crest cells (NCCs) that reach the frontonasal
region and form much of the facial skeleton or subsequent failure of NCC patterning
and differentiation into bone and cartilage. While loss of gene expression is often
associated with developmental defects, aberrant upregulation of expression can also
be detrimental. microRNAs (miRNAs) are a class of non-coding RNAs that normally
repress gene expression by binding to recognition sequences located in the 3′ UTR of
target mRNAs. miRNAs play important roles in many developmental systems, including
midfacial development. Here, we take advantage of high throughput RNA sequencing
(RNA-seq) from different tissues of the developing mouse midface to interrogate the miRs
that are expressed in the midface and select a subset for further expression analysis.
Among those examined, we focused on four that showed the highest expression level
in in situ hybridization analysis. Mir23b and Mir24.1 are specifically expressed in the
developing mouse frontonasal region, in addition to areas in the perichondrium, tongue
musculature and cranial ganglia. Mir23b is also expressed in the palatal shelves and in
anterior epithelium of the palate. In contrast,Mir133b andMir128.2 are mainly expressed
in head and trunk musculature. Expression analysis of mir23b and mir133b in zebrafish
suggests thatmir23b is expressed in the pharyngeal arch, otic vesicle, and trunk muscle
while mir133b is similarly expressed in head and trunk muscle. Functional analysis by
overexpression of mir23b in zebrafish leads to broadening of the ethmoid plate and
aberrant cartilage structures in the viscerocranium, while overexpression of mir133b
causes a reduction in ethmoid plate size and a significant midfacial cleft. These data
illustrate thatmiRs are expressed in the developing midface and thatMir23b andMir133b
may have roles in this developmental process.
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INTRODUCTION
Morphogenesis of the vertebrate face is a complex event
requiring coordination among a variety of signaling cascades.
Human craniofacial birth defects occur at a world-wide rate
of 1:800 births (Schutte and Murray, 1999; Spritz, 2001), with
structural defects often resulting from failure of spatio-temporal
integration of these signaling cascades. While the vertebrate
mid-face has a complex embryonic origin, most facial birth
defects result from disruption of cranial neural crest cell (NCC)
patterning and differentiation (Chai and Maxson, 2006; Knight
and Schilling, 2006; Walker and Trainor, 2006; Dixon et al.,
2011; Clouthier et al., 2013). Cranial NCCs arise at the border
between the neural and non-neural ectoderm and subsequently
migrate to the frontonasal region (Le Douarin, 1982; Bronner-
Fraser, 1995). These cells eventually give rise to most of the
bone, cartilage, and connective tissue of the mid-face and
neck (Couly et al., 1996; Köntges and Lumsden, 1996). NCC
development relies on intricate regulation of patterning cues
within specific boundaries of the head. While boundaries are
established through continuous refinement of gene expression,
the mechanisms required for this refinement are less clear.
MicroRNAs (miRNAs) are a class of small, noncoding RNAs
that inhibit translation of target mRNAs by binding to a
recognition sequence almost always in the 3′ untranslated region
(UTR) of the target mRNA (Lee et al., 1993; Wightman et al.,
1993; Lai, 2002; Lewis et al., 2003). This binding results in
decreased mRNA translation through a number of mechanisms
that can include cleavage and degradation of the target mRNA,
translational repression, deadenylation of the 3′-poly(A) tail and
thus mRNA decay and miRNA sponging (Hutvágner et al., 2001;
Zheng and Cullen, 2003; Wu et al., 2006; Hausser and Zavolan,
2014; Jens and Rajewsky, 2015). miRNAs have been implicated
in many clinically relevant processes, including development,
cancer, and stem cell maintenance and differentiation (Chen
et al., 2012; Fernández-Hernando et al., 2013; Kuppusamy et al.,
2013;Morceau et al., 2013; Parpart andWang, 2013). miRNAs are
also involved in numerous aspects of craniofacial development,
including palatogenesis, odontogenesis, and upper and lower jaw
development (Tavares et al., 2015). One of the first examples of
miRNA action in facial development ismir140, whose regulation
of pdgfra is required for NCCs to migrate past the optic stalk
on their way from the hindbrain to the future palate (Eberhart
et al., 2008). A SNP in the humanMIR140 gene leads to reduced
Mir140 expression in murine palatal mesenchymal cells (Li et al.,
2011). In addition, this SNP is associated with increased risk
of nonsyndromic cleft palate in mothers who smoke during
pregnancy (Li et al., 2010). These findings suggest that miRNA
function is evolutionarily conserved and illustrates a role for
miRNAs in human palate development. Another miRNA family
involved in craniofacial development is the MIR17 and MIR92
family, which has been linked to Feingold syndrome in human
patients (Kannu et al., 2013; Tassano et al., 2013). Targeted
knockouts of Mir17 and Mir92 in mice results in hypoplasia of
most skull bones, including reduced ossification and cleft palate,
similar to human patients (Ventura et al., 2008; de Pontual et al.,
2011; Li et al., 2012; Wang et al., 2013). In addition, others, such
as Mir196, Mir199, and Mir200 have likely roles in determining
craniofacial size, bone and cartilage formation, and cartilage
size, respectively (Watanabe et al., 2008; Desvignes et al., 2014).
However, targeted deletion of the miRNA processing enzyme
DICER in NCCs results in hypoplasia of most craniofacial
structures, suggesting that numerous other miRNAs are also
likely involved in this process (Huang et al., 2010; Zehir et al.,
2010; Nie et al., 2011; Oommen et al., 2012).
Here, we use data from a high-throughput miRNA sequencing
project of developing mouse facial structures to identify
many miRNAs that are potentially involved in craniofacial
development. We have examined the expression of a number
of these miRNAs in both mouse and zebrafish. Further, we
have performed functional analysis of four of these miRNAs in
zebrafish. Our in situ hybridization and overexpression analyses
provide evidence that Mir23b and Mir133b are important
regulators of craniofacial development.
MATERIALS AND METHODS
miRNA-Seq Differential Expression
Analysis
RNA-Seq count data with gene assignments have been
deposited in the FaceBase repository for craniofacial research
(www.facebase.org). Specific FaceBase accession numbers
are: E10.5 FB00000662.01, E11.5 FB00000663.01, E12.5
FB00000664.01, FB00000664.01, E13.5 FB00000665.01, E14.5
FB00000666.01. Counts of overlapping and nested sequences
assigned to each mature (1035 sequences) or hairpin (306
sequences) mouse miRNA were summed to obtain consolidated
counts per mature or hairpin miRNA (724 and 255, respectively).
A threshold of 1 was used for the RNA-seq analysis. After low
filtering (mean counts per sample >5; 629 mature miRs and
163 hairpin miRNAs), we used DESeq to identify miRNAs
differentially expressed by anatomy or age. For principal
components analysis and hierarchical clustering, count data
was normalized using the regularized log transformation in the
DESeq R package. A p < 0.01 after multiple testing correction
(Benjamini and Hochberg method) was used, as well as no
fold-change threshold (Benjamini and Hochberg, 1995).
Mouse and Zebrafish Maintenance
All mouse embryo collection was performed using 129S6 mice
(Taconic), with the day of the copulation plug denoted as 0.5 days.
Embryo collection and fixation were performed as previously
described (Clouthier et al., 1998). Zebrafish were maintained
according to common lab practice (Westerfield, 2000), with
embryo staging according to established methods (Kimmel et al.,
1995). The wild type lines used are AB and an in-cross line
maintained between the AB and TL lines (TAB). This study
was carried out in accordance with the recommendations of the
Institutional Animal Care and Use Committee (IACUC) of the
University of Colorado Anschutz Medical Campus as laid out
in protocols approved by IACUC. Nomenclature for miRNAs
is consistent with that described in Desvignes et al. (2015).
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For simplicity, pri-MiR(mouse) and pri-miR (zebrafish) were
annotated without the “pri” in the text below.
Cloning and Probe Synthesis
To detect expression of mouse MiRNAs, we used both Locked
Nucleic Acid (LNA; Obernosterer et al., 2007) and conventional
riboprobes against the primary pri-MiR transcripts, both labeled
with digoxigenin (He et al., 2011). For LNA-based experiments,
Exiqon LNA Mir133b (#616614-360) and Mir23b (#615366-360)
probes were used. To generate pri-MiR probes, PCR primers
were designed to amplify about 200–600 nt of the primary MiR
transcript centered on the mature miRNA sequence for mouse
and zebrafish. All primer sequences are given in Supplemental
Table 1. To generate mouse pri-MiRs, PCR primers were used
with genomic tail DNA obtained from tails of 2 month old mice.
To generate zebrafish pri-miRs, PCR primers were used with 5
day post fertilization (dpf) zebrafish embryos. PCR products were
cloned into the pCR R©II-TOPO R© Vector (Invitrogen). Inserts
were validated by sequencing. Plasmids were linearized and
transcribed using the DIG Labeling Kit (Roche). Probes were
purified as previously described (Clouthier et al., 1998). The
opposite stand sense probes were used as controls for specificity
for the antisense expression (data not shown).
Mouse and Zebrafish Whole Mount In situ
Hybridization (ISH)
Whole mount ISH in mouse was performed as previously
described (Clouthier et al., 1998). For sectional miRNA ISH,
serial 10µm frontal sections through the head of E12.5 and/or
E13.5 mouse embryos were collected on Superfrost Plus slides
(Fisher). Subsequent ISH was performed as previously described
(Hendershot et al., 2007). Hybridizations were performed at
70◦C overnight. Colorimetric detection was performed with BM
purple (Roche). Signal detection required an average of 2–3
days in staining solution. After developing, slides were rinsed
in TBST, coverslipped and photographed using Nomarski optics
on an Olympus BX51 compound microscope fitted with a DP71
digital camera. Whole-mount ISH in zebrafish was performed as
previously described (Johnson et al., 2011). BM Purple (Roche)
was used as a substrate for the alkaline phosphatase reaction.
After staining, embryos were mounted in 80% glycerol or 3%
methylcellulose and imaged under Nomarski optics on the
Olympus BX51 compound microscope as described for mice.
Overexpression Analysis and Bone and
Cartilage Staining
MiRNA duplexes were created by annealing 5p and 3p MiRs
together at 95◦C and slowly cooling to room temperature
(MiR133b-3p: UUUGGUCCCCUUCAACCA; MiR133b-5p:
GCUGGUCAAAUGGAACCA; MiR23b-3p: AUCACAUUG
CCAGGGAUU; MiR23b-5p: GGUUCUUGGCAUGCUGA).
Thirty-three micrometers of MiR23b duplex (5′—3′), 6.25µM
of MiR133b (5′—3′), and 33µM of standard control miRNA
(5′- CTTACCTCAGTTACAATTTATA -3 duplexed with 5′-
TAAATTGTAACTGAGGTAAGAG-3′) were injected into single
cell zebrafish embryos and allowed to grow for 6 dpf. Zebrafish
embryos were fixed and stained with alizarin red and alcian blue
(Birkholz et al., 2009) with minor modifications. Larvae were
fixed in 2% PFA/PBS for 1 h at room temperature, washed in
100mM Tris (pH 7.5)/10mM MgCl2, and stained overnight
in 0.04% alcian blue (Anatech Ltd) in 80% EtOH/100mM
Tris (pH 7.5)/10mM MgCl2. Larvae were then rehydrated in
80% EtOH/100mM Tris (pH 7.5)/10mM MgCl2, followed
by 50 and 25% EtOH/100mM Tris (pH 7.5), cleared in 25%
glycerol/0.1% KOH, then stained 30min with 0.01% alizarin
red (Sigma) in 25% glycerol/100mM Tris (pH 7.5) and stored
in 50% glycerol/0.1% KOH. Stained skeletons were dissected,
flat-mounted and imaged as previously described (Johnson et al.,
2011).
RESULTS
Identification of miRNAs Involved in
Midfacial Development from miRNA-Seq
Data
We have previously conducted massively parallel miRNA
sequencing (miRNA-Seq) on miRNAs extracted from embryonic
age (E) 10.5, E11.5, E12.5, E13.5, and E14.5 mouse maxillary
prominences, frontonasal prominences, and palatal shelves, with
the data deposited in FaceBase (www.facebase.org). Between
E10.5 and E11.5, NCC-derived mesenchyme that will give
rise to craniofacial structures undergoes significant patterning
events that establishes the positional and functional identity of
the mesenchyme. Between E12.5 and E14.5, gene expression
in the facial region is driving differentiation into the bone
and cartilage of the upper and lower face. Because we are
interested in the mechanisms that govern this second event,
we focused our analysis of miRNA expression between E12.5
and E14.5. Using a combination of biostatical approaches
and packages (Section Materials and Methods), we identified
262 differentially expressed mature miRNAs and 71 hairpin
miRNAs at a false discovery rate-adjusted p > 0.01 (data not
shown). Of these, 49 mature miRNAs and 11 hairpin miRNAs
were differentially expressed between maxillary prominences,
frontonasal prominences, and palatal shelves (Figure 1A);
some also differed by age (Figure 2). Table 1 shows the top
differentially expressed miRNAs as total counts, while Figure 2
shows the log2fold change in expression of specific miRNAs
between facial prominences at E13.5. Total counts of each
miRNA are also shown in Table 1 so that the relative expression
of miRNAs can be compared.
Principal Components Analysis of miRNAs
Expressed in the Face
Principal Components Analysis (PCA) is a primary quality
control assay, with the expectation that replicates will cluster
and that principal components might reflect known qualities of
the sample conditions (e.g., age, anatomy) or of the experiment
(e.g., batch or read depth). After sequence consolidation and
low-expression filtering, normalized counts for 979 miRNAs
(724 mature miRNAs and 255 hairpin miRNAs) were used to
analyze the principal components of the variability among the
24 samples (Figure 1B). The first principal component, which
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FIGURE 1 | Analysis of miRNA-Seq data defines miRNAs whose expression differs by prominence. (A) 49 mature miRNAs and 11 hairpin miRNAs were
differentially expressed by prominence (FDR adjusted p < 0.01). Hierarchical clustering of their normalized and scaled expression values (using the R hclust function,
ward. D2 method) shows groups of miRNAs enriched in the frontonasal prominence (FnP), palate (Pal), the maxillary prominence (Max), or in combinations thereof.
The dendrogram at the top shows the clustering of the samples; the three major divisions correspond to FnP, Pal, and Max, and duplicate samples cluster together.
(B) Principal Component Analysis (PCA) analysis of data. Data is color coded by age (inset), with tissue source denoted by symbol (inset). Principal Component 1
(PC1) distributes samples by age. Principal Component 2 (PC2) is orthogonal to PC1 but does not correspond to any obvious property of the samples.
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FIGURE 2 | RNAseq values for expression of selected miRNAs. Normalized counts for selected miRNAs from each prominence (see inset) as compared to
embryonic age (E10–15). Each row represents a different pattern of expression over time. (Top) Mir15a, Mir130b, and Mir301a showed a downward trend of
expression over time. (Middle) Expression of Mir133b, Mir24.1, and Mir1282 increased over time. (Bottom) Mir23b, Mir27b, and Mir130a were expressed
consistently over time. Blue, Maxillary prominence; Green, Frontonasal prominence; and Purple, Palate.
accounts for 26% of the variability, distributed the samples
by age (color-coded). Neither prominence (symbols) nor read
depth (not shown) correlated with any of the top five principal
components. Biological duplicates from E10.5-E12.5 tended
to cluster, indicating biological reproducibility at those ages.
Together these demonstrate the biological reproducibility for key
miRNAs between replicates and within prominences.
Expression Analysis of Selected miRNAs in
the Mouse at E12.5
For our in situ hybridization (ISH) analysis of miRNA expression
in the developing midface, we focused on E12.5 mouse embryos,
as at this stage, the lateral and medial nasal prominences,
palatal shelves, and maxilla are well-defined and are undergoing
extensive growth. We initially examined miRNA expression
in E12.5 mouse embryo using whole mount ISH and LNA
probes against Mir23b, Mir24.1, and Mir666 (Supplemental
Figure 1). LNA probes specifically detect the mature Mir
sequence. However, the overall level of expression of these
Mir’s as detected in whole mount analysis was low (likely due
in part to poor probe penetration; Supplemental Figure 1),
leading us to examine Mir expression using frozen sectional
ISH analysis. When using LNA probes against Mir23b and
Mir133b, robust expression was present in a variety of facial
structures, though overall background staining on the sections
was high (Supplemental Figure 2). To next assess whether we
could improve the signal to noise ratio of the staining, we
PCR-generated probes against the pri-miRNA transcript, an
approach we have previously used to examine Mir expression in
embryos (He et al., 2011). Probes encompassed the pri-miRNA
sequence (see (Section) Materials and Methods). These probes
detect both pri-miRNAs and mature miRNAs, so expression
is expected in both the nucleus and cytoplasm. However, the
relative abundance of mature miRNAs for any single species
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TABLE 1 | microRNAs that are differentially expressed between prominences at E13.5.
Normalized counts
microRNA Fn (1) Fn (2) Mx (1) Mx (2) Pal (1) Pal (2) Pattern
MIR1a-3p 911.78 711.95 9059.94 11523.71 3472.3 4385.36 Pal&Mx
MiR128.2 45.21 20.06 444.7 181.49 157.72 24.72 Pal&Mx
MIR133a-3p 67.82 165.42 3063.12 1421.33 628.5 722.18 Pal&Mx
MIR133a-5p 11.3 23.03 225.67 249.28 47.79 186.84 Pal&Mx
MIRp133b-3p 0 10.9 560.85 203.36 109.93 186.37 Pal&Mx
MIR133b-3p,
MIR133a-3p
41.44 77.51 5883.99 1478.18 1049.1 781.84 pAL&Mx
MIR184-3p 97.96 97.57 829.67 467.95 389.53 285.26 Pal&Mx
MIR206-3p 678.18 281.07 26993.99 23655.32 13105.35 10618 Pal&Mx
MIR214-3p 14901.2 6127.98 19507.09 17443.01 20518.33 28066.97 Pal&Mx
MIR483-3p 331.56 253.33 1158.21 682.24 924.83 584.54 Pal&Mx
MIR499-5p 15.07 25.01 235.62 308.32 52.57 156.18 Pal&Mx
MIR3099-3p 90.42 48.54 132.75 124.64 136.22 154.51 Pal&Mx
MIR137-3p 56.52 67.36 185.84 67.79 143.38 911.87 Pal>Mx
MIR483-5p 350.39 151.8 487.84 756.59 642.84 1184.77 Pal>Mx
let-7e-5p 3142.25 3950.77 2216.87 5053.38 4698.23 15721.97 Pal
MIR31-3p 11.3 37.64 19.91 21.87 64.52 221.07 Pal
MIR31-5p 877.87 1350.11 365.05 531.36 1464.91 4273.87 Pal
MIR135a-2-3p 18.84 22.29 46.46 54.67 114.71 150.47 Pal
MIR376c-3p 184.62 181.02 348.46 419.84 291.55 841.27 Pal
MIR450a-2-3p 3.77 29.22 6.64 4.37 23.9 68.46 Pal
MIR495-3p 565.15 1077.21 1181.44 1176.42 996.52 2931.26 Pal
MIR500-3p 470.96 430.88 418.15 750.03 630.89 1213.3 Pal
MIR873a-3p 94.19 61.91 146.02 67.79 611.77 54.44 Pal
MIR873a-5p 60.28 75.78 23.23 41.55 157.72 174.24 Pal
MIR1251-5p 26.37 91.38 89.6 61.23 133.83 434.07 Pal
MIR7b-5p 768.61 226.09 49.78 61.23 1032.37 305.46 Fn>Pal
MIR200a-3p 13639.02 20365.01 2598.51 3391.51 3345.64 13267.57 Fn&Pal
MIR9-3p 968.3 1467.98 89.6 104.96 71.69 139.54 Fn
MIR9-5p 7490.16 4400.23 726.79 763.15 365.63 487.32 Fn
MiR23b 380.54 244.91 79.65 104.96 86.03 71.31 Fn
MiR141 259.97 162.7 26.55 48.11 26.29 51.35 Fn
MiR200a 862.8 569.81 149.34 150.88 303.5 66.32 Fn
MIR200b-3p 141254.31 59360.85 7055.47 17631.06 15461.64 23046.91 Fn
MIR200b-5p 779.91 289.98 73.01 96.21 164.89 87.48 Fn
MIR3085-3p 3.77 29.72 13.27 8.75 7.17 9.75 Fn
MIR429-3p 5218.24 10519.04 1085.2 1445.38 1930.91 3339.65 Fn
MiR653 195.92 80.98 33.19 102.77 69.3 63.71 Fn
Mir19b.1 184.62 198.11 59.74 170.56 50.18 146.67 Fn> Mx
MiR27b 64.05 23.77 19.91 8.75 4.78 5.94 Fn> Mx
MIR200a-5p 678.18 249.12 79.65 87.47 95.59 62.99 Fn> Mx
MiR429 327.79 131.99 39.82 76.53 28.68 43.03 Fn> Mx
MIR215-5p 75.35 54.97 6.64 13.12 4.78 3.09 Fn> Mx
MiR18a 33.91 36.9 26.55 15.31 14.34 28.29 Fn & Mx
MIR18b-5p 52.75 48.29 13.27 32.8 9.56 64.9 Fn & Mx
MIR20b-5p 437.05 646.33 172.57 321.44 114.71 422.89 Fn & Mx
MIR27b-5p 440.82 129.02 73.01 181.49 64.52 78.68 Fn & Mx
MiR92a.2 832.66 1542.27 1025.47 848.43 1493.59 657.99 Fn & Mx
MIR106a-5p 290.11 252.84 69.69 177.12 33.46 192.07 Fn & Mx
MiR106b 128.1 70.82 49.78 59.04 23.9 22.82 Fn & Mx
MIR182-3p 395.61 350.16 126.11 65.6 148.16 99.36 Fn & Mx
(Continued)
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TABLE 1 | Continued
Normalized counts
microRNA Fn (1) Fn (2) Mx (1) Mx (2) Pal (1) Pal (2) Pattern
MIR293-3p 11.3 11.39 13.27 13.12 4.78 10.7 Fn & Mx
MIR302a-5p 30.14 20.06 26.55 34.99 11.95 23.77 Fn & Mx
MIR302b-3p 18.84 85.68 53.1 39.36 33.46 70.84 Fn & Mx
MIR302d-3p 48.98 84.2 46.46 72.16 43.02 117.67 Fn & Mx
MiR326 26.37 26.5 29.87 26.24 23.9 7.84 Fn & Mx
MiR3473f 7.54 9.66 13.27 26.24 0 5.71 Fn & Mx
MIR582-3p 391.84 241.69 574.13 301.76 210.3 69.89 Fn & Mx
MiR6399 26.37 4.46 9.96 4.37 2.39 1.19 Fn & Mx
MiR6539 45.21 13.12 16.59 30.61 14.34 15.93 Fn & Mx
MIR18b-3p 0 4.21 0 0 2.39 0.95 Mx>Fn
MIR128.1-5p 90.42 33.93 172.57 48.11 64.52 28.76 Mx>Fn
MIR211-5p 131.87 119.11 242.26 74.35 21.51 15.93 Mx>Fn
MIR216b-5p 26.37 52.99 33.19 8.75 2.39 19.97 Mx>Fn
MIR217-5p 22.61 21.3 13.27 30.61 2.39 7.84 Mx>Fn
MIR363-3p 252.43 832.8 504.44 284.27 446.88 173.53 Mx>Fn
MiR486 26.37 6.44 132.75 83.09 28.68 6.89 Mx>Fn
MIR741-3p 3.77 2.72 23.23 0 0 1.66 Mx>Fn
Colored and bolded areas indicate groups of miRs that are highly expressed within a specific prominence. Green, Frontal nasal prominence (Fn); Brown, Maxilla (Mx); Pink, Palate (Pal).
TABLE 2 | Expression profiles of miRNAs in the developing mouse midface.
miRNA Embryonic age Expression profile
Mir15a E12.5 Tongue, oral and nasal epithelium, nasal mesenchyme
Mir20a E12.5 Eye, lung, brain
Mir23b E12.5, E13.5 Naris, vibrissae, TG, DRG, palatal shelf, maxilla, tongue, nasal and tongue epithelium, tongue muscle, incisor, otic capsule, malleus,
diencephalon, limb muscle, mesothelium, intervertebral space, foregut, gastrointestinal neurons
Mir24.1 E12.5, E13.5 Vibrissae, TG, DRG, nasal epithelium, maxilla, tongue, incisor, limb muscle, gastrointestinal neurons, mesothelium, intervertebral space,
pinna
Mir27b E12.5 Tongue, limb, rib, pinna, TG, nasal epithelium, eye, vibrissae, brain, facial cartilage, intestinal neuron
Mir128.2 E12.5, E13.5 Maxilla, TG, DRG, tongue, diencephalon, telencephalon, ocular muscles, limb, mesothelium, ribs
Mir130a E12.5 Tongue, rib, limb, intestine, facial cartilage, nasal epithelium, maxilla
Mir130b E12.5 Tongue, intestine, facial cartilage, nasal epithelium, maxilla
Mir133b E12.5, E13.5 Vibrissae, maxilla, TG, tongue, intervertebral space, hyoid, ocular muscles, diencephalon, muscle, mesothelium, ribs
Mir206 E12.5 Tongue, rib, limb, eye, maxilla, nasal epithelium
Mir335 E12.5 Tongue, brain
Mir376 E12.5 Tongue, rib, mandible, vertebrae, lateral nasal prominence
Mir411 E13.5 Tongue, proximal mandible and mesenchyme of the outflow tract, maxillary mesenchyme
Mir666 E12.5, E13.5 FNP, DRG, ocular muscle, tongue, mandible, vertebrae, mesothelium, ribs, liver, spinal cord, limb
compared to that of pri-miRNA species makes it far more
likely that these probes detect the mature miRNA. Further, we
have shown that the use of pri-miRNA probes for miRNA ISH
provides comparable results to those using LNA probes (He
et al., 2011). Based on our bioinformatics analysis (Figures 1,
2), we examined the expression of 13 pri-miRNAs in E12.5
mouse embryos and found that many were expressed in specific
embryonic tissues, including facial structures (Table 2 and
Supplemental Figures 3–9). Based on this initial analysis of
ISH data, we focused our subsequent analysis on MiR23b and
MiR133b.
Expression of MiR23b and MiR133b in
Mouse Facial Structures at E12.5
In E12.5 wild type mouse embryos, MiR23b expression
appeared throughout the facial region including the nasal
epithelium, mystacial vibrissae, and vomeronasal nasal organs
(Figures 3A–C), upper incisors (Figure 3D), tongue connective
tissue and epithelium (Figures 3E,F), and maxillary epithelium
(Figure 3F). Expression was also observed in the anterior palatal
shelves, with expression more prominent on the nasal side
of the shelves (Figures 3E,F) and in the trigeminal ganglion
(Figure 3G). In addition, MiR23b was expressed along the
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FIGURE 3 | Expression of Mir23b in mouse facial structures at E12.5. ISH analysis in frozen frontal sections through the head of E12.5 mouse embryos. (A–C)
Mir23b is moderately expressed in the nasal epithelium epithelium (ne), mystacial vibrissae (mv), nasal septum (ns), and vomeronasal organ (vo). (D–F) Mir23b is also
expressed in the upper incisors (i), tongue (t), maxillary epithelium (te), and palatal shelves (ps). The arrow in (F) denotes the epithelium where Mir23b expression
begins. (G–I) More posteriorly, expression is observed in the trigeminal ganglion (tg; G), posterior tongue (t; H,I). i, incisor; mx, maxilla; oc, oral cavity.
palatal shelf epithelium, again starting at the midline of the
shelf and continuing on the oral side (Figures 3H,I). Overall,
the expression pattern of MiR23b supported our analysis
(Figure 1), though it was difficult to assess the qualitative
differences in expression between prominences compared to the
quantitative differences of miRNA-seq. In the genome, MiR23b
is part of the 850 bp Mirc23 cluster, which contains Mir23b,
Mir27b, and Mir3074.1. In addition, Mir24.1 is 5 kb away from
Mir23b. As previously described for many clustered miRNAs
(Lagos-Quintana et al., 2003; Lim et al., 2003), Mir24.1 had
an expression pattern similar to that observed for Mir23b,
including expression in the nasal epithelium (Supplemental
Figures 3A–C), tongue (Supplemental Figures 3E,F,H,I) and
maxillary process epithelium (Supplemental Figure 3D), though
expression in the palatal shelf mesenchyme and overlying
epithelium (Supplemental Figures 3D,F,H,I) and trigeminal
ganglia (Supplemental Figure 3G) was weak.
Like MiR23b, MiR133b was also strongly expressed in the
craniofacial region at E12.5. Weak expression was observed
in the nasal epithelium, mystacial vibrissae and maxilla
(Figures 4A–C), but strong expression was observed in facial
musculature, including the intrinsic and extrinsic musculature of
the tongue and eye (Figures 4D–I) and facial muscles (including
the masseter muscle (arrow; Figure 4F). Expression of MiR133b
was not observed in the maxilla or palatal shelves, suggesting that
the expression observed by miRNA-seq might reflect presence of
other tissue in dissected samples. LikeMir23b,Mir133b exists in a
cluster withMir206, which had a similar pattern of expression to
that ofMir133b. Message was primarily detected in facial muscles
(Supplemental Figures 4E,F), with message also detected in the
cornea and lens of the eye (Supplemental Figure 4A). Further,
like the comparison between MiR23b and MiR24.1, expression
of MiR206 was much weaker than the expression observed for
MiR133b.
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FIGURE 4 | Expression of Mir133b in mouse facial muscles at E12.5. ISH analysis in frozen frontal sections through the head of E12.5 mouse embryos. (A–C)
Mir133b is weakly expressed in the nasal epithelium (ne; A), mystacial vibrissae (mv; B), and maxilla (mx); (D–F). (mx); (D–F). Mir133b is strongly expressed in facial
muscles, including the masseter (ma), and in the muscles of the eye (em; D) and tongue muscle (t; E–I) Expression is not observed in the palatal shelves (ps; E,F).
(G–I) Posterior expression continues continues in the tongue muscles. e, eye; oc, oral cavity.
Expression of mir23b and mir133b is
Conserved in Zebrafish Facial Structures
Based on analysis ofmir140 action, miRNA function during facial
development is also present in zebrafish embryos. Similarly, we
found that a selected subset of the miRNAs from Table 1 were
also expressed in the head region of 30-hours post fertilization
(hpf) zebrafish embryos (Table 3 and Supplemental Figure 10).
To examine whether the pattern of expression of mir23b and
mir133b was also conserved between mouse and zebrafish
embryos, we examined expression of both miRNAs in 30–72 hpf
embryos. Expression of mir23b was detected in the head and
pharyngeal arch mesenchyme (Figure 5A) and in the somitic
mesoderm (Figure 5D) at 30 hpf. Diffuse expression was also
present in the eye (Figure 5A). At 48 hpf, mir23b expression was
still present in the head and pharyngeal arch mesenchyme while
also appearing in the otic vesicle (Figure 5B). Expression was
also observed in the trunk muscle and notochord (Figure 5E).
By 72 hpf, expression remained in cranial muscle (Figures 5C,G)
while also being present in the somite-derived trunk muscle and
notochord (Figure 5F) and in ceratobranchial structures (arrows,
Figure 5G).
At 30 hpf, mir133b expression was also observed in the head
region (around the eye and portions of the brain; Figure 6A),
though expression was weaker than that of mir23b. Expression
was quite strong in the developing somites (Figure 6D). By
48 hpf, expression around the otic vesicle, eye, and posterior
brain was increased (Figures 6B,G). As in 30 hpf embryos,
mir133b was strongly expressed in the somites (Figure 6E).
By 72 hpf, mir133b expression was observed in trunk muscles
(Figure 6F), otic vesicle and heart (Figure 6C). Expression
was also present in the facial muscles, including the anterior
mandibularis (arrow, Figure 6H) and muscles developing near
the ceratobranchials, including the stemohyoideus (arrowheads,
Figure 6H).
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TABLE 3 | Expression profiles of miRNAs in the developing zebrafish.
miRNA Embryonic age Expression profile
mir15a 48 and 72 hpf Midbrain, MHB, notochord
mir15b 48 and 72 hpf Midbrain, neurocranium, notochord
mir23b 30, 48, and 72 hpf Somites, lens, pharyngeal arches, notochord
mir27b 48 and 72 hpf
mir30c 48 and 72 hpf Brain, neurocranium, eye, heart
mir130a 48 and 72 hpf Brain, gut tube, heart, eye
mir133b 30, 48, and 72 hpf Notochord
mir301a 48 and 72 hpf Forming cartilage
Midbrain, neurocranium, eye, trigeminal ganglia
mir23b and mir133b Overexpression
Results in Viscerocranial and Neurocranial
Defects in Zebrafish
Two potential methods for assessing function of genes in
zebrafish are over-expression and gene inactivation. While
Crispr-Cas9-mediated gene inactivation is underway, we
began our analysis of potential function by injecting 1–2 cell
zebrafish embryos with duplex RNA for MiR23b and MiR133b
examining cartilage development at 6 dpf. Overexpression
of miRNA duplex is more likely to generate a phenotype, as
increasing the repressor function will result in reduced gene
expression of the miRNA gene targets. In the viscerocranium,
MiR23b duplex injection resulted in aberrant development
of Meckel’s cartilage and the ceratohyal (Figure 7B). In
addition, ectopic cartilage extended from the basihyal to the
medial aspect of Meckel’s cartilage (23/128; 18%; Figure 7B).
Two bilateral ectopic cartilages also extended anteriorly
from Meckel’s cartilage. Morphological changes were also
present in the neurocranium, including a slight increase
in the width of the ethmoid plate likely resulting from a
shortening of the trabeculae (74/128; 58%; Figures 7F,I)
as compared to standard control MiR injected embryos
(n = 10; Figures 7D,H,I) and control non-injected embryos
(Figures 7A,E).
Injection of duplex RNA for MiR133b resulted in the
formation of a cleft in the ethmoid plate (40/89; 45%; Figure 7G)
and a general reduction in the overall size of the neurocranium,
with a significant reduction in both the ethmoid plate width and
length (46/89; 52%; Figures 7G,I). Injected animals also showed
a mild change in the viscerocranium, including a reduction in the
size of the ceratohyal (Figure 7C).
DISCUSSION
miRNAs have well defined roles in numerous developmental
process, including craniofacial development (Tavares et al., 2015).
We have shown here that numerous miRNAs are expressed
within the developing midface, with expression patterns for
some of these suggesting distinct functions in a variety of
tissues. In addition, we have shown that over-expression of
mir23b and mir133b results in changes in craniofacial cartilage
morphogenesis. Together, results from our study illustrate the
utility of an approach to quickly assess potential miRNA function
during vertebrate morphogenesis.
Identification of miRNAs in Craniofacial
Development
In addition to the identification of novel miRNAs expressed
in the craniofacial complex, several miRNAs identified in this
study as differentially expressed between facial prominences and
over time have been identified to play a role in development in
other systems. Mir199a, which we found to be enriched in the
palate as compared to the FNP at E13.5, is involved in aspects of
chondrogenesis and osteogenesis (Suomi et al., 2008; Lin et al.,
2009). Similarly, Mir92a which is in the Mirc1 cluster on mouse
chromosome 14 containing Mir17, Mir18, Mir19a, Mir20a,
Mir19b-1, and Mir92a-1, is required to promote proliferation
of orofacial development (Ning et al., 2013). Thus, these data
confirm and validate the deep sequencing data. Other groups
have performed miRNA expression profiling of the developing
mouse orofacial region using microarrays (Mukhopadhyay et al.,
2010) and have found similar differential expression across time
for miRNAs that included Mir133a and Mir133b. Interestingly,
Mir23b was not identified by microarray analysis. This may be
due to the retrospective nature of microarray studies, as they
are limited by the total number of miRNAs that are present
on the microarray chip. This approach may exclude all of the
transcribed miRNAs in the genome. By definition, the inclusion
of miRNAs on microarray chips means that the miRNA has
already been identified and annotated. Furthermore, because
microarrays are generally based on genome sequence, they may
not assay miRNAs that originate by post-transcriptional editing
(de Hoon et al., 2010). In contrast, miRNA-seq is prospective:
it identifies all miRNAs present in a sample, regardless of
whether they have been annotated or not or whether they
have experienced editing. Thus, miRNA-seq has the power
to identify novel and edited miRNAs in addition to known
miRNAs.
miRNA-seq was recently used on avian embryos, in which
dissection of the chick, quail and duck FNPs followed by miRNA-
seq identified 170 miRNAs that were differentially expressed
between the three species (Powder et al., 2012). Interestingly,
several miRNAs were found to be avian-specific, suggesting that
miRNAs may have promoted the evolutionary diversification of
facial shape and beak formation.
Potential Mir23b and Mir133b Functions
and Targets
Here we have shown that Mir23b is expressed in the developing
face of mouse embryos and in the head of zebrafish embryos
and that its overexpression in zebrafish embryos results in
ectopic cartilage structures in the viscerocranium. This may
indicate roles for Mir23b in regulating either patterning of the
NCC-derived mesenchyme or later chondrogenesis. One of the
interesting aspects our data analysis (Figure 1) is that Mir27b
expression is also present in the developing midface, with its
expression mirroring that of Mir23b. In mouse, Mir23b is part
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FIGURE 5 | Expression of mir23b in zebrafish embryos. Whole-mount in situ hybridization analysis with a digoxigenin-labeled probe against the mir23b transcript
at 30–72 hpf. (A–C) Expression is observed in the otic vesicle (ov; A), weakly in the eye (e), and pharyngeal arch (B,C), and palate (pl; C). (D–F) In the trunk,
expression is observed in the trunk muscle the somites (s; E,D) at 30, 48 hpf, and trunk muscle (tm; F) at 72 hpf. (G) Ventral view of expression shows more detailed
expression in the cranial muscle including the muscles supporting the craniofacial structures (arrows) and the eye. Anterior is to the left. n, notochord; ch, ceratohyal.
of a miRNA cluster that includes Mir23b, Mir27b, Mir3074.1,
and Mir24.1. In zebrafish, this corresponds to mir23b, mir27d,
and mir24.1. mir23b and mir27b are separated by less than 200
bp, though it is not clear that their expression is co-regulated.
In the fetal mouse liver, the Mir23b cluster regulates cell fate
switch between hepatocytes and bile duct cells by regulating
expression of Smad3, 4, and 5 and thereby repressing TGF-
β signaling (Rogler et al., 2009). This negative regulation of
TGF-β signaling is interesting, as proper regulation of TGF-β
signaling is crucial for proper craniofacial development (Behnan
et al., 2005). Marfan syndrome results from aberrant TGF-
β signaling due to the failure of fibrullin-1 to bind to and
sequester the latent form of TGF-β (Neptune et al., 2003;
Chaudhry et al., 2007). Conversely, loss of TGF-β signaling is
also detrimental tomidfacial development, with loss of numerous
TGF family members leading to facial birth defects (Iwata
et al., 2011), illustrating the importance of miRNA regulation.
While our miRNA-seq data suggests that the two miRNAs
are co-expressed, further analysis of embryonic expression and
loss-of-function phenotypes for individual miRNAs and the
clusters will be required to fully understand their function.
This is especially true for Mir23b and Mir27b, as while
both work concurrently to drive cardiomyocyte development
from ES cells in vitro, Mir23b subsequently controls the later
beating phenotype of differentiated cells while Mir27b functions
to inhibit this event (Chinchilla et al., 2011; Wang et al.,
2012). Our analysis of expression and function in zebrafish
suggest that mir23b is expressed in the pharyngeal arch
mesenchyme and potentially functions to promote proliferation
of chondrocytes, such that when overexpressed, ectopic cartilage
arises.
Mir133b resides in a cluster that includes Mir206 and
Mir133b. This family is referred to as myomiRs because they
regulate genes involved in adult muscle formation. In addition,
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FIGURE 6 | Expression of mir133b in zebrafish embryos. Whole-mount in situ hybridization analysis with a digoxigenin-labeled probe against mir133b at
30–72 hpf. (A–C) Expression is observed in the developing pharyngeal region, including at 48 hpf in the facial muscle (fm) and otic vessicle (B,G). (D–F) Strong
expression of miR133b is observed in the somites (s; D) at 30 hpf, somites (E), and pectoral fin (pf) at 48 hpf (H) and facial muscle (fm; C), cardiac muscle (cm; C), and
trunk muscle (tm; F) at 72 hpf, including the anterior mandibularis (arrows) and stemohyoideus (arrowheads) facial muscles muscles. Anterior is to the left. e, eye; tm,
trunk muscle; n, notochord; ch, ceratohyal.
Mir133b is down-regulated in several cancers, including muscle
rhabdomyosarcoma, osteosarcoma, and prostate, colorectal and
gastric cancers (Namløs et al., 2012; Qin et al., 2012; Mo et al.,
2013). In these abnormal contexts, MIR133b in human cervical
carcinoma targets EGFR and FGFR1, similarly acting as a tumor
suppressor (Namløs et al., 2012). Interestingly, both EGF and
FGF signaling have been implicated in craniofacial development.
Mutations in EGF signaling have been implicated in human
clefting (Falagan-Lotsch et al., 2015) and cranial suture formation
in mice (Rawlins et al., 2008). More roles have been ascribed
for FGF signaling in craniofacial development, with FGFR1
specifically linked to skeletal dysplasias and craniosynostosis
in both humans and mice, suggesting a mechanism by which
Mir133b may regulate craniofacial development (Moosa and
Wollnik, 2016). Changes in facial muscle can affect development
of facial bone and cartilages (Reider et al., 2012). From our
expression analysis, it is plausible that overexpression ofMir133b
may lead to changes in facial muscle which affects subsequent
viscerocranium development.
In addition, Mir133b is involved in the differentiation
of dopaminergic neurons. Zebrafish mir133b is expressed in
the midbrain at low levels and regulates pitx3 to control
dopaminergic neuron differentiation (Sanchez-Simon et al.,
2010). In contrast, mice in which Mir133b has been inactivated
have normal dopaminergic neuron numbers and normal PITX3
protein levels (Heyer et al., 2012) even though Mir133b can
target the Pitx3 message. This suggests the possibility that
other Mir133 family members with the same seed sequence
(GGACCAAA; i.e., Mir133a, Mir133c) can compensate for loss
of Mir133b. Mir133b is clustered in the genome with Mir
206.1, which does not have the same seed sequence but is
predicted to bind some of the same targets in mouse including
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FIGURE 7 | Injection of MiR133b and MiR23b RNA duplexes resulted in facial defects. Alcian blue stain of 6 dpf zebrafish larvae, flat mounted ventral views,
anterior is to the left. (A,D,E,H) Control embryos, either uninjected or 33µM control miR-injected, display wild type type craniofacial cartilage in both the
viscerocranium and neurocranium. (B,F) Injection of 33µM RNA duplex of MiR23b leds to a slight increase in the width of the ethmoid plate, likely resulting from
shortening of the trabeculae (tr) (F), and production of ectopic cartilage (*; B) in the B) in the viscerocranium. (C,G) Injection of 6.25µM RNA duplex of MiR133b
resulted in hypoplastic cartilage structure and a cleft (*) in the ethmoid plate (ep; G,I). (I) Quantification of ethmoid plate length and width comparing standard control
MiR (n = 10) injected with 33µM compared to MiR23b (n = 9) and MiR133b (n = 9). Elements were measured and the mean and standard deviation for each are:
Ethmoid plate length for control MiR, 380 ± 13.23µm; MiR23b, 396 ± 27.13µm; and MiR133b, 355 ± 19.27µm; Ethmoid plate width for control MiR, 169.2 ±
4.92µm; MiR23b, 193.9 ± 193.9 ± 14.09µm; and MiR133b: 144.7 ± 14.7µm. Student’s (Welsh’s) T-test was used to compare to the standard control using
GraphPad PRISM. *p < 0.02 and ***p < 0.0008. Anterior is to the left. cb, ceratobranchial; ch, ceratohyal; mc, Meckel’s cartilage; n, notochord; pq, palatoquadrate.
Histone Deacetylase 4, DNA Polymerase α, and Connexin43
(Anderson et al., 2006; Chen et al., 2006; Kim et al., 2006;
Goljanek-Whysall et al., 2012). mir133b has the potential to
target the same set of myogenic targets in zebrafish, but only
Histone Deacetylase 4 contains a seed sequence for mir133b.
More work is needed to distinguish between these possibilities.
While we have not determined the numbers of dopaminergic
neurons in zebrafish in which mir133b is over-expressed, we
do see specific defects in cartilage differentiation, including
hypoplasia of the ethmoid plate and specific gaps or missing
cartilage in the viscerocranium, suggesting that mir133b may
act non-cell autonomously to regulate cartilage differentiation.
While there is little known about a direct role of mir133b
on the development of the craniofacial cartilage, these results
suggest that it is involved in both muscle and neuronal
development, both of which can influence, either directly or
indirectly, formation of the craniofacial complex. In summary,
our results illustrate multiple MiRNAs are expressed in the
developing face. This analysis will allow for more focused
analysis of miR function in both zebrafish andmouse craniofacial
development.
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